Results

Reset All Filters

Manufacturer:DCChemicals remove filter

Oncology

Revealing the molecular mechanism of tumor development and identifying the matching inhibitory candidates is one important area within the cancer research.

The tumor diversity is extremely high. Therefore, cancer research belongs to the high variant research areas with manifold scientific approaches.

To match this challenge, we offer you a unique diversity of products for your oncology research and development in the academic and pharmaceutical field.

Click on the organs and learn more about cancer types

General information

Oncologists focus on the diagnosis, therapy and follow-up of cancer.
Cancer is a class of diseases in which cells start to divide uncontrollably and invade other tissues. Cancer cells can spread to other parts of the body via the blood and lymphatic system. Under physiological conditions, cell proliferation is tightly controlled by many mechanisms. In addition, the immune system is able to recognize and destroy cancer cells. If these mechanisms fail or the immune system cannot effectively destroy the cells, it can lead to a malignant tumor. Theoretically, a malignant neoplasm can occur everywhere, but there are cancers that are more often than others. For men it is the prostate and in women it is the mammary gland.

Relevant products for oncology research

Name	Type	Specific against	Item no.	Amount	Price
2-PMPA(NAALADaseinhibitor)	Inhibitors	Other	DCC-DC10014-1g DCChemicals	1 g	Login Compare	2-PMPA(NAALADaseinhibitor)
Ustekinumab	Chemicals	Other	DCC-A022-10mg DCChemicals	10 mg	Login Compare	Ustekinumab
Secukinumab	Chemicals	Other	DCC-A019-10mg DCChemicals	10 mg	Login Compare	Secukinumab
VPS34 inhibitor 1 (Compound 19, PIK-III analogue)	Inhibitors	Other	DCC-DC10019-10mg DCChemicals	10 mg	Login Compare	VPS34 inhibitor 1 (Compound 19, PIK-III analogue)
Ustekinumab	Chemicals	Other	DCC-A022-25mg DCChemicals	25 mg	Login Compare	Ustekinumab
Secukinumab	Chemicals	Other	DCC-A019-25mg DCChemicals	25 mg	Login Compare	Secukinumab
VPS34 inhibitor 1 (Compound 19, PIK-III analogue)	Inhibitors	Other	DCC-DC10019-25mg DCChemicals	25 mg	Login Compare	VPS34 inhibitor 1 (Compound 19, PIK-III analogue)
Ustekinumab	Chemicals	Other	DCC-A022-100mg DCChemicals	100 mg	Login Compare	Ustekinumab
Secukinumab	Chemicals	Other	DCC-A019-100mg DCChemicals	100 mg	Login Compare	Secukinumab
VPS34 inhibitor 1 (Compound 19, PIK-III analogue)	Inhibitors	Other	DCC-DC10019-50mg DCChemicals	50 mg	Login Compare	VPS34 inhibitor 1 (Compound 19, PIK-III analogue)
Stat5 Inhibitor(STAT5-IN-1)	Inhibitors	Other	DCC-DC10139-250mg DCChemicals	250 mg	Login Compare	Stat5 Inhibitor(STAT5-IN-1)
Stat5 Inhibitor(STAT5-IN-1)	Inhibitors	Other	DCC-DC10139-1g DCChemicals	1 g	Login Compare	Stat5 Inhibitor(STAT5-IN-1)
Stat5 Inhibitor(STAT5-IN-1)	Inhibitors	Other	DCC-DC10139-100mg DCChemicals	100 mg	Login Compare	Stat5 Inhibitor(STAT5-IN-1)
Pax2 inhibitor EG1	Inhibitors	Other	DCC-DC21457-100mg DCChemicals	100 mg	Login Compare	Pax2 inhibitor EG1
Pax2 inhibitor EG1	Inhibitors	Other	DCC-DC21457-250mg DCChemicals	250 mg	Login Compare	Pax2 inhibitor EG1
Pax2 inhibitor EG1	Inhibitors	Other	DCC-DC21457-1g DCChemicals	1 g	Login Compare	Pax2 inhibitor EG1
CD73 inhibitor AB-680	Inhibitors	Other	DCC-DC21981-100mg DCChemicals	100 mg	Login Compare	CD73 inhibitor AB-680
CD73 inhibitor AB-680	Inhibitors	Other	DCC-DC21981-250mg DCChemicals	250 mg	Login Compare	CD73 inhibitor AB-680
mTOR inhibitor-1	Inhibitors	Other	DCC-DC20230-100mg DCChemicals	100 mg	Login Compare	mTOR inhibitor-1
TrkA inhibitor compound 23（TrkA-IN-23）	Inhibitors	Other	DCC-DC20280-10mg DCChemicals	10 mg	Login Compare	TrkA inhibitor compound 23（TrkA-IN-23）
mTOR inhibitor-1	Inhibitors	Other	DCC-DC20230-250mg DCChemicals	250 mg	Login Compare	mTOR inhibitor-1
TrkA inhibitor compound 23（TrkA-IN-23）	Inhibitors	Other	DCC-DC20280-25mg DCChemicals	25 mg	Login Compare	TrkA inhibitor compound 23（TrkA-IN-23）
mTOR inhibitor-1	Inhibitors	Other	DCC-DC20230-1g DCChemicals	1 g	Login Compare	mTOR inhibitor-1
TrkA inhibitor compound 23（TrkA-IN-23）	Inhibitors	Other	DCC-DC20280-100mg DCChemicals	100 mg	Login Compare	TrkA inhibitor compound 23（TrkA-IN-23）
Tegatrabetan	Chemicals	Other	DCC-DC20756-100mg DCChemicals	100 mg	Login Compare	Tegatrabetan

Name Price

2-PMPA(NAALADaseinhibitor)

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	DCC-DC10014-1g
Amount	1 g
Available

Ustekinumab

Type	Chemicals
Clone
Specific against	Other
Appl.
Host
Item no.	DCC-A022-10mg
Amount	10 mg
Available

Secukinumab

Type	Chemicals
Clone
Specific against	Other
Appl.
Host
Item no.	DCC-A019-10mg
Amount	10 mg
Available

VPS34 inhibitor 1 (Compound 19, PIK-III analogue)

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	DCC-DC10019-10mg
Amount	10 mg
Available

Ustekinumab

Type	Chemicals
Clone
Specific against	Other
Appl.
Host
Item no.	DCC-A022-25mg
Amount	25 mg
Available

Secukinumab

Type	Chemicals
Clone
Specific against	Other
Appl.
Host
Item no.	DCC-A019-25mg
Amount	25 mg
Available

VPS34 inhibitor 1 (Compound 19, PIK-III analogue)

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	DCC-DC10019-25mg
Amount	25 mg
Available

Ustekinumab

Type	Chemicals
Clone
Specific against	Other
Appl.
Host
Item no.	DCC-A022-100mg
Amount	100 mg
Available

Secukinumab

Type	Chemicals
Clone
Specific against	Other
Appl.
Host
Item no.	DCC-A019-100mg
Amount	100 mg
Available

VPS34 inhibitor 1 (Compound 19, PIK-III analogue)

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	DCC-DC10019-50mg
Amount	50 mg
Available

Stat5 Inhibitor(STAT5-IN-1)

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	DCC-DC10139-250mg
Amount	250 mg
Available

Stat5 Inhibitor(STAT5-IN-1)

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	DCC-DC10139-1g
Amount	1 g
Available

Stat5 Inhibitor(STAT5-IN-1)

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	DCC-DC10139-100mg
Amount	100 mg
Available

Pax2 inhibitor EG1

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	DCC-DC21457-100mg
Amount	100 mg
Available

Pax2 inhibitor EG1

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	DCC-DC21457-250mg
Amount	250 mg
Available

Pax2 inhibitor EG1

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	DCC-DC21457-1g
Amount	1 g
Available

CD73 inhibitor AB-680

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	DCC-DC21981-100mg
Amount	100 mg
Available

CD73 inhibitor AB-680

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	DCC-DC21981-250mg
Amount	250 mg
Available

mTOR inhibitor-1

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	DCC-DC20230-100mg
Amount	100 mg
Available

TrkA inhibitor compound 23（TrkA-IN-23）

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	DCC-DC20280-10mg
Amount	10 mg
Available

mTOR inhibitor-1

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	DCC-DC20230-250mg
Amount	250 mg
Available

TrkA inhibitor compound 23（TrkA-IN-23）

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	DCC-DC20280-25mg
Amount	25 mg
Available

mTOR inhibitor-1

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	DCC-DC20230-1g
Amount	1 g
Available

TrkA inhibitor compound 23（TrkA-IN-23）

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	DCC-DC20280-100mg
Amount	100 mg
Available

Tegatrabetan

Type	Chemicals
Clone
Specific against	Other
Appl.
Host
Item no.	DCC-DC20756-100mg
Amount	100 mg
Available

Oncology

Click on the organs and learn more about cancer types

General information

Relevant products for oncology research

Contact

About Hölzel

Service

Infodesk

REGISTER & SECURE BENEFITS

Filter Results

Oncology

Click on the organs and learn more about cancer types

General information

Relevant products for oncology research

Contact

About Hölzel

Service

Infodesk